Return to content in this issue

Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience

Baynova K¹, Cimbollek S¹, Quiralte J¹, García R², Lucena JM², Lasa Luaces E³, Lara Jiménez MA⁴, Alvarez Nieto J⁵, Moreto J⁶, González-Quevedo T<sup>1

1</sup>National Angioedema Reference Unit, Allergology Department, Virgen del Rocío University Hospital, Seville, Spain
²Immunology Department, Virgen del Rocío University Hospital, Seville, Spain
³Pediatric Allergology Unit, Allergology Department, Donostia University Hospital, Donostia, Spain
⁴Allergology Unit, San Cecilio University Hospital, Granada, Spain
⁵CSL Behring España S.A., Barcelona, Spain
⁶Ampersand Consulting, Barcelona, Spain

J Investig Allergol Clin Immunol 2024; Vol 34(3) : 198-199
doi: 10.18176/jiaci.0948

• Abstract
• Supplemental Materials

Key words: Hereditary angioedema, C1 esterase inhibitor, Subcutaneous replacement therapy

	Title	Type	Size
	doi10.18176_jiaci.0948_supplemental-materials1.pdf	pdf	227.58 Kb
	doi10.18176_jiaci.0948_supplemental-materials2.pdf	pdf	115.46 Kb
	doi10.18176_jiaci.0948_supplemental-materials3.pdf	pdf	103.68 Kb